10/15/2021
Ethos Medical began as a capstone project with a goal to improve epidural placement in 2018. With the help of CREATE-X and GCMI’s T3 labs, Ethos was able to validate their device through preclinical feasibility studies with practicing emergency room physicians and identify important procedure improvements. These studies will be critical as Ethos aims to complete FDA regulatory clearance in late 2022.
https://gcmiatl.com/2021/09/22/from-capstone-through-create-x-and-on-to-the-precipice-of-commercialization-ethos-medicals-medtech-journey-for-its-novel-spinal-guidance-system/